VRQOL in Cataract Patients During the COVID-19 Pandemic
Assessment of Vision-related Quality of Life (VRQOL) in Cataract Patients During the COVID-19 Pandemic
1 other identifier
observational
116
1 country
1
Brief Summary
The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2020
CompletedFirst Posted
Study publicly available on registry
July 13, 2020
CompletedStudy Start
First participant enrolled
September 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedSeptember 23, 2020
June 1, 2020
6 months
June 22, 2020
September 22, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Improvement Vision-related quality of life
Extent of improvement of vision-related qualitiy of life due to cataract surgery measured with the National Eye Institut Visual Function Questionnaire 25.
3 months
Secondary Outcomes (2)
Delay of Vision-related quality of life
3 months
Visual acuity
1 month
Study Arms (1)
Senile Cataract
Patient with senile cataract, whose cataract surgery was postponed in the COVID-19 pandemic
Interventions
Patients complete the National Eye Institute Visual Function Questionnaire 25 pre-operative, 1 month and 3 month postoperatively.
Eligibility Criteria
Patients with senile cataract with indication for for unilateral or bilateral cataract surgery.
You may qualify if:
- Age ≥ 50 years
- Senile cataract
- Indication for unilateral or bilateral cataract surgery
- Postponed cataract surgery due to the COVID-19 pandemic
- Signed and dated declaration of consent
You may not qualify if:
- Complex form of cataract (traumatic cataract, secondary cataract after intraocular inflammation)
- Amblyopia on the eye that is to be operated on
- Severe, visually impairing eye disease on the eye that is to operated on
- Known dementia or memory problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Innsbruck
Innsbruck, Tyrol, 6020, Austria
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2020
First Posted
July 13, 2020
Study Start
September 8, 2020
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
September 23, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share